Key result
Enteroviruses interact with the NLRP3 inflammasome, with viral proteins 2B and 3D promoting its activation while 2A and 3C antagonize it to evade host innate immunity.
Why the study?
Enteroviruses are a substantial public health threat causing mild to severe disease, but little is known about their pathogenesis.
This review highlights the dual role of enterovirus proteins in regulating the NLRP3 inflammasome, providing potential targets for novel antiviral therapies.
Does not support clinical use of NLRP3 modulators in enterovirus infections; leaves open mechanistic targets for future antiviral trials.
Enteroviruses (EVs) have emerged a substantial threat to public health. EVs infection range from mild to severe disease, including mild respiratory illness, diarrhea, poliomyelitis, hand, foot, and mouth disease, aseptic meningitis, and encephalitis. In the Asia-Pacific region, for example, one of the best studied enterovirus 71 (EV71) has been associated with pandemics of hand, foot, and mouth disease (HFMD) in children, particularly those under the age of five. Serious HFMD cases are associated with neurological complications, such as aseptic meningitis, acute flaccid paralysis, brainstem encephalitis, and have been associated with as many as 1000s of deaths in children and infants from 2008 to 2017, in China. More than 90% of laboratory confirmed deaths due to HMFD are associated with EV71. However, little is known about the pathogenesis of EVs. Studies have reported that EVs-infected patients with severe complications show elevated serum concentrations of IL-1β. The secretion of IL-1β is mediated by NLRP3 inflammasome during EV71 and CVB3 infection. Enteroviruses 2B and 3D proteins play an important role in activation of NLRP3 inflammasome, while 3C and 2A play important roles in antagonizing the activation of NLRP3 and the secretion of IL-1β. In this review, we summarize current knowledge regarding the molecular mechanisms that underlie the activation and regulation of the NLRP3 inflammasome, particularly how viral proteins regulate NLRP3 inflammasome activation. These insights into the relationship between the NLRP3 inflammasome and the pathogenesis of EVs infection may ultimately inform the development of novel antiviral drugs.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2019) conducted a review in Enterovirus infection. Enteroviruses was evaluated. Enteroviruses interact with the NLRP3 inflammasome, with viral proteins 2B and 3D promoting its activation while 2A and 3C antagonize it to evade host innate immunity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: